Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease - Concepedia

Concepedia

Publication | Open Access

Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease

DOI Full Paper Access

20

Citations

41

References

2021

Year

Sandra Neumann, Jodi Taylor, Alison Bamford, Chris Metcalfe, Daisy Gaunt, Alan Whone, Diana Steeds, Stevan R. Emmett, William Hollingworth, Yoav Ben‐Shlomo,

References

	Year	Citations

Page 1